We’re conducting a short one-question poll to determine treatment preferences for mCSPC. If you’re a physician or APP, please respond below. Thank you!


A healthy 71-year-old male is discovered to have metastatic prostate cancer in the spine and two ribs. He has no symptoms. He was told not to have a PSA but one was obtained for an insurance physical and was 450 ng/ml. Your preferred treatment for mCSPC is:


Researcher-physician E. David Crawford, MD, Jack A. Vickers Director of Prostate Research and Professor of Urology at the University of California, San Diego, has devoted his career in medicine to educating the public about men's health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.